$2.08
00.00%
Pre-Market: 7:57 AM EDT
Comments
Loading...
Longeveron (LGVN) Forecast
NewsEarningsLongeveron (LGVN) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestLongeveron (NASDAQ:LGVN) Stock Quotes, Forecast and News Summary
Longeveron Stock (NASDAQ: LGVN) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Longeveron (LGVN) stock?
You can purchase shares of Longeveron (NASDAQ:LGVN) through any online brokerage.
Who are Longeveron (LGVN) competitors?
Other companies in Longeveron’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and GlycoMimetics (NASDAQ:GLYC).
What is the forecast, or price target, for Longeveron (LGVN) stock?
Longeveron has a consensus price target of $10.25.
What is the current price for Longeveron (LGVN)?
The stock price for Longeveron (NASDAQ: LGVN) is $2.08 last updated November 15, 2024 at 7:57 AM EST.
Does Longeveron (LGVN) pay a dividend?
There are no upcoming dividends for Longeveron.
When is Longeveron (NASDAQ:LGVN) reporting earnings?
Longeveron’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
Is Longeveron (LGVN) going to split?
There is no upcoming split for Longeveron.
What sector and industry does Longeveron (LGVN) operate in?
Longeveron is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.